Nektar Therapeutics | NKTR - Ordinary Share Capital


Nektar Therapeutics reported $29.47M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 59.6M 264K Jun/2026
ALKERMES USD 168.03M 489K Sep/2026
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amgen USD 541M 0 Sep/2026
Baxter International USD 517M 549K Jun/2026
BioCryst Pharmaceuticals USD 255.26M 42.2M Jun/2026
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 7M Jun/2026
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Cipla INR 807.87M 88K Sep/2026
Dr.Reddys Laboratories INR 833.07M 382K Sep/2026
Eisai JPY 282.46M 345K Jun/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Exelixis USD 244.68M 4.21M Sep/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 2.02B 2.05B Sep/2026
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 113.94M 106K Sep/2026
Incyte USD 200.98M 1.03M Jun/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 22.54M 4.23M Mar/2026
MacroGenics USD 63.65M 86K Jun/2026
Merck USD 2.47B 1.05M Jun/2026
Nektar Therapeutics USD 29.47M 9.09M Mar/2026
Neurocrine Biosciences USD 101.3M 750K Sep/2026
Novartis USD 1.89B 12.09M Sep/2026
Pfizer USD 5.7B 0 Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sarepta Therapeutics USD 107.23M 1.61M Sep/2026
Takeda JPY 1.58B 460K Jun/2026
Teva Pharmaceutical Industries USD 1.17B 2M Sep/2026
Xencor USD 74.33M 265K Jun/2026